{"title":"Solute Carrier Family 2 Member 1 Gene Mutation Presenting as Adult-Onset Paroxysmal Exercise-Induced Dyskinesia Without Epilepsy.","authors":"Yun Su Hwang, Eungseok Oh","doi":"10.3988/jcn.2024.0349","DOIUrl":"10.3988/jcn.2024.0349","url":null,"abstract":"","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 6","pages":"627-629"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Konstantina Stavrogianni, Dimitrios K Kitsos, Vasileios Giannopapas, Maria-Ioanna Stefanou, Niki Christouli, Vassiliki Smyrni, Athanasios K Chasiotis, Alexandra Akrivaki, Evangelia Dimitriadou, Maria Chondrogianni, Georgios Tsivgoulis, Sotirios Giannopoulos
{"title":"Impact of Siponimod on Clinical and Radiological Parameters of Secondary Progressive Multiple Sclerosis: A Real-World Prospective Study.","authors":"Konstantina Stavrogianni, Dimitrios K Kitsos, Vasileios Giannopapas, Maria-Ioanna Stefanou, Niki Christouli, Vassiliki Smyrni, Athanasios K Chasiotis, Alexandra Akrivaki, Evangelia Dimitriadou, Maria Chondrogianni, Georgios Tsivgoulis, Sotirios Giannopoulos","doi":"10.3988/jcn.2024.0149","DOIUrl":"10.3988/jcn.2024.0149","url":null,"abstract":"<p><strong>Background and purpose: </strong>Secondary progressive multiple sclerosis (SPMS) presents with a challenging clinical phenotype, and siponimod has a potential to treat the active clinical phenotype of this disease. This single-center longitudinal study aimed to determine the therapeutic effects of siponimod in patients with active SPMS over 12 months.</p><p><strong>Methods: </strong>The clinical and radiological parameters of 50 patients with active SPMS treated using siponimod were assessed at baseline and after a 1-year follow-up period using the annual relapse rate (ARR), the Expanded Disability Status Scale (EDSS), the occurrence of gadolinium-enhanced lesion (GdE+), the Modified Fatigue Impact Scale (MFIS), and the Symbol Digit Modalities Test. The urine bladder postvoid residual (PVR) volume was also measured in a subcohort of 39 participants. Participants with an EDSS score ≥5.0 at baseline were finally assessed separately in prespecified subgroup analyses.</p><p><strong>Results: </strong>There were significant reductions in ARR (<i>p</i><0.001), GdE+ (<i>p</i><0.001), and MFIS score (<i>p</i>=0.001) during the follow-up period. The progression of physical and cognitive disabilities remained stable (<i>p</i>>0.05). The PVR-volume analysis revealed a significant decrease in urine bladder PVR volume (<i>p</i><0.001). These observations were consistent for the subgroup with EDSS score ≥5.0.</p><p><strong>Conclusions: </strong>Siponimod demonstrated efficacy in reducing ARR, GdE+, fatigue levels, and PVR volume, while maintaining stability in the cognitive and physical disability statuses of patients with SPMS. Similar findings were documented in the subgroup with EDSS score ≥5.0.</p>","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 6","pages":"591-598"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jae Young Park, Sang Hee Ha, Soo Jeong, Jun Young Chang, Dong-Wha Kang, Sun U Kwon, Bum Joon Kim
{"title":"Association Between Vertebral Arterial Tortuosity and Aneurysm Growth in Intracranial Vertebral Artery Dissection.","authors":"Jae Young Park, Sang Hee Ha, Soo Jeong, Jun Young Chang, Dong-Wha Kang, Sun U Kwon, Bum Joon Kim","doi":"10.3988/jcn.2024.0139","DOIUrl":"10.3988/jcn.2024.0139","url":null,"abstract":"<p><strong>Background and purpose: </strong>An intracranial vertebral artery dissecting aneurysm (iVADA) increases the risk of future subarachnoid hemorrhage, which is a severe complication with high rebleeding rates and poor outcomes. Identifying potential risk factors associated with iVADA growth is crucial for their effective management.</p><p><strong>Methods: </strong>This observational study was carried out at a single center and included patients who had been diagnosed with iVADA based on neuroimaging findings. We divided the patients into two groups: with and without iVADA growth. Growth was defined as any enlargement of a dilated region or a morphological change in follow-up imaging. We measured the vertebral artery tortuosity index (VTI) in the contralateral vertebral artery (VA), defined as its actual length divided by its straight length. We investigated the factors associated with iVADA growth.</p><p><strong>Results: </strong>This study included 124 patients. The median follow-up period was 7 months. We observed iVADA growth in 54 patients (43.5%), who were more likely to be current smokers (33.3% vs. 14.3%, <i>p</i>=0.012) and have a higher VTI (1.14±0.11 [mean±standard deviation] vs. 1.06±0.12, <i>p</i>=0.035) compared with those without iVADA growth. A multivariate analysis revealed that the VTI (adjusted odds ratio=28.490, 95% confidence interval=1.025-792.046, <i>p</i>=0.048) was independently associated with iVADA growth.</p><p><strong>Conclusions: </strong>This study has identified an independent association between VA tortuosity and iVADA growth.</p>","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 6","pages":"617-623"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Keun-Tae Kim, Jeong-Heon Lee, Jun-Pyo Hong, Jin-Woo Park, Sun-Uk Lee, Euyhyun Park, Byung-Jo Kim, Ji-Soo Kim
{"title":"Blood Pressure Variability and Ocular Vestibular-Evoked Myogenic Potentials Are Independently Associated With Orthostatic Hypotension.","authors":"Keun-Tae Kim, Jeong-Heon Lee, Jun-Pyo Hong, Jin-Woo Park, Sun-Uk Lee, Euyhyun Park, Byung-Jo Kim, Ji-Soo Kim","doi":"10.3988/jcn.2024.0092","DOIUrl":"10.3988/jcn.2024.0092","url":null,"abstract":"<p><strong>Background and purpose: </strong>We delineated the association between otolithic dysfunction and blood pressure (BP) variability.</p><p><strong>Methods: </strong>We prospectively recruited 145 consecutive patients (age=71 [59-79] years, median [interquartile range]; 76 females) with orthostatic intolerance between December 2021 and December 2023 at a tertiary hospital in South Korea. Each patient underwent evaluations of cervical and ocular vestibular-evoked myogenic potentials (oVEMPs), 24-h noninvasive ambulatory BP monitoring (ABPM), and a head-up tilt-table test using the Finometer device. As measures of BP variability, the standard deviations (SDs) of the systolic BP (SBP<sub>SD</sub>) and the diastolic BP were calculated based on serial ABPM recordings. Patients were divided into those with orthostatic hypotension (OH, <i>n</i>=68) and those with a normal head-up tilt-table test despite orthostatic intolerance (NOI, <i>n</i>=77) groups.</p><p><strong>Results: </strong>A multivariable logistic regression analysis showed that OH was associated with bilateral oVEMP abnormalities (<i>p</i>=0.021), SBP<sub>SD</sub> (<i>p</i>=0.012), and female sex (<i>p</i>=0.004). SBP<sub>SD</sub> was higher in patients with OH than in those with NOI (<i>p</i><0.001), and was not correlated with n1-p1 amplitude (<i>p</i>=0.491) or normalized p13-n23 amplitude (<i>p</i>=0.193) in patients with OH. The sensitivity and specificity for differentiating OH from NOI were 72.1% and 67.5%, respectively, at a cutoff value of 12.7 mm Hg for SBP<sub>SD</sub>, with an area under the receiver operating characteristic curve of 0.73.</p><p><strong>Conclusions: </strong>Bilaterally deficient oVEMP responses may be associated with OH regardless of 24-h BP variability, reflecting the integrity of the otolith-autonomic reflex during orthostasis. Alternatively, 24-h BP variability is predominantly regulated by the baroreflex, which also participates in securing orthostatic tolerance complementary to the vestibulo-autonomic reflex.</p>","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 6","pages":"571-579"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sevim Gökmen, Halit Fidancı, Halil Can Alaydın, Elif Banu Söker
{"title":"Neurophysiological Tests in a Myasthenia Gravis Patient With Muscle-Specific Kinase Antibody Accompanied by Myotonic Discharges.","authors":"Sevim Gökmen, Halit Fidancı, Halil Can Alaydın, Elif Banu Söker","doi":"10.3988/jcn.2024.0347","DOIUrl":"10.3988/jcn.2024.0347","url":null,"abstract":"","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 6","pages":"624-626"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CGG Repeat Expansion in <i>NOTCH2NLC</i> Causing Overlapping Oculopharyngodistal Myopathy and Neuronal Intranuclear Inclusion Disease With Diffusion Weighted Imaging Abnormality in the Cerebellum.","authors":"Jing Ma, Huiqiu Zhang, Bing Meng, Jiangbo Qin, Hongye Liu, Xiaomin Pang, Rongjuan Zhao, Juan Wang, Xueli Chang, Junhong Guo, Wei Zhang","doi":"10.3988/jcn.2023.0486","DOIUrl":"10.3988/jcn.2023.0486","url":null,"abstract":"<p><strong>Background and purpose: </strong>CGG repeat expansion in the 5' untranslated region (5'UTR) of the Notch 2 N-terminal-like C gene (<i>NOTCH2NLC</i>) has been associated with neuronal intranuclear inclusion disease (NIID) and oculopharyngodistal myopathy type 3 (OPDM3). Few OPDM3 patients have been reported. This report describes two OPDM3 patients with novel imaging findings who presented the typical features of NIID, and reviews all OPDM3 cases available in the literature.</p><p><strong>Methods: </strong>The available clinical, imaging, and pathological information was reviewed and investigated. CGG repeat expansion in the 5'UTR of <i>NOTCH2NLC</i> was tested using the repeat-primed polymerase chain reaction (PCR), followed by the fluorescence amplicon-length PCR to determine the number of CGG repeats.</p><p><strong>Results: </strong>Our two OPDM3 patients and most patients reported in the literature developed the typical clinical characteristics of NIID, including leukoencephalopathy, peripheral neuropathy, cognitive deterioration, pigmentary retinopathy, ataxia, tremor, acute encephalitis-like episodes, pigmentary retinopathy, miosis, and sensorineural hearing loss. In addition to typical imaging findings of NIID, our two patients exhibited diffusion weighted imaging (DWI) hyperintensities in the middle cerebellar peduncles, which have not been described previously. Muscle biopsies revealed rimmed vacuoles and p62-positive intranuclear inclusions in the myofibers in both patients. The skin biopsy performed in one patient detected typical eosinophilic intranuclear inclusions. Genetic analysis identified CGG repeat expansion in <i>NOTCH2NLC</i> as the causative mutation in the two patients.</p><p><strong>Conclusions: </strong>Our two patients with OPDM3 had clinical characteristics of NIID and exhibited DWI abnormality in the cerebellum. Our results indicate that OPDM3 is within the spectrum of NIID and that DWI hyperintensities in the cerebellum are helpful for diagnosing NIID or OPDM3.</p>","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 6","pages":"580-590"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543384/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seoyeon Kim, Ji-Soo Kim, Seung-Han Lee, Jae-Myung Kim, Seunghee Na, Jae-Hwan Choi, Hyo-Jung Kim
{"title":"Intellectual Disability in Episodic Ataxia Type 2: Beyond Paroxysmal Vertigo and Ataxia.","authors":"Seoyeon Kim, Ji-Soo Kim, Seung-Han Lee, Jae-Myung Kim, Seunghee Na, Jae-Hwan Choi, Hyo-Jung Kim","doi":"10.3988/jcn.2024.0274","DOIUrl":"10.3988/jcn.2024.0274","url":null,"abstract":"<p><strong>Background and purpose: </strong>Episodic ataxia type 2 (EA2) is characterized by recurrent vertigo and ataxia due to mutations in <i>CACNA1A</i> that encodes the α<sub>1A</sub>-subunit of the P/Q-type voltage-gated calcium channel. This study aimed to determine intellectual function in EA2.</p><p><strong>Methods: </strong>During 2019-2023, 13 patients (6 males, age range=10-52 years, median age=29 years) with a genetically confirmed diagnosis of EA2 had their intellectual function evaluated using the Korean versions of the Wechsler Intelligence Scales (version IV) for adults or children in 3 referral-based university hospitals in South Korea.</p><p><strong>Results: </strong>The full-scale intelligence quotients (FSIQs) among the 13 patients were below the average (90-109) in 11, low average (80-89) in 5 (38.5%), borderline (70-79) in 1 (7.7%), and indicated intellectual disability (≤69) in 5 (38.5%). These patterns of cognitive impairments were observed in all four of the following subtests: verbal comprehension, perceptual reasoning, working memory, and processing speed. The FSIQ was not correlated with the ages at onset for vertigo and ataxia (Pearson correlation: <i>p</i>=0.40).</p><p><strong>Conclusions: </strong>Patients with EA2 may have hidden intellectual disabilities even without a history of epilepsy or administration of antiepileptic drugs, and should be considered for genetic counseling and therapeutic interventions. Given the availability of medication to control episodic vertigo and ataxia, early diagnosis and management are important in preventing irreversible brain dysfunction in EA2.</p>","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 6","pages":"563-570"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Validation of the Karolinska Sleepiness Scale in Korean.","authors":"Sungkyoung Shin, Sujin Lee, Su Jung Choi, Eun Yeon Joo, Sooyeon Suh","doi":"10.3988/jcn.2024.0042","DOIUrl":"10.3988/jcn.2024.0042","url":null,"abstract":"<p><strong>Background and purpose: </strong>The Karolinska Sleepiness Scale (KSS) is widely used for assessing current level of sleepiness, but it has not been validated in South Korea. This study aimed to validate the KSS using the Stanford Sleepiness Scale (SSS), polysomnography (PSG), and electroencephalography (EEG).</p><p><strong>Methods: </strong>The sample consisted of 27 adult participants in this study aged 40.5±7.7 years (mean±standard deviation) and included 22 males. They completed questionnaires and underwent EEG recording and overnight PSG. The KSS was completed from 18:00 to 24:00 every 2 hours and following PSG (at 07:00). KSS scores changed over time and in particular increased with the time since waking, with the score peaking at 24:00.</p><p><strong>Results: </strong>Convergent validity of the KSS was verified by performing a Spearman correlation analysis between the KSS and SSS (<i>r</i>=0.742, <i>p</i><0.01). Concurrent validity of the KSS was verified by performing a Spearman correlation analysis between the KSS administered before sleep and the sleep onset latency measured using PSG (<i>r</i>=-0.456, <i>p</i><0.05). Alpha waves were measured 5 minutes before administering the KSS, and the KSS scores were compared with these alpha waves. There were no significant correlations observed between the KSS scores and alpha waves measured in the left occipital area (O1), left frontal area (F3), or left central area (C3). In addition, Spearman correlation analyses of the difference between KSS scores and alpha waves measured at O1, F3, and C3 produced no significant results.</p><p><strong>Conclusions: </strong>This study verified the convergent validity and concurrent validity of the KSS, and confirmed the capabilities of this scale in assessing sleepiness changes over time.</p>","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 5","pages":"501-508"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jinse Park, Wooyoung Jang, Jinyoung Youn, Eungseok Oh, Suyeon Park, Yoonsang Oh, Hee-Tae Kim, Soohyun Lim
{"title":"Validity and Reliability of the Korean Versions of the 9- and 19-Item Wearing-Off Questionnaires in Parkinson's Disease.","authors":"Jinse Park, Wooyoung Jang, Jinyoung Youn, Eungseok Oh, Suyeon Park, Yoonsang Oh, Hee-Tae Kim, Soohyun Lim","doi":"10.3988/jcn.2023.0339","DOIUrl":"10.3988/jcn.2023.0339","url":null,"abstract":"<p><strong>Background and purpose: </strong>The wearing-off (WO) phenomenon is the most common motor complication in advanced Parkinson's disease (PD), but its identification remains challenging. The 9- and 19-item Wearing-off Questionnaires (WOQ-9 and WOQ-19) are self-assessment tools for motor and nonmotor symptoms that are widely used for WO screening. We produced Korean versions of the WOQ-19 and WOQ-9 (K-WOQ-19 and K-WOQ-9) and investigated their validity and reliability.</p><p><strong>Methods: </strong>We used the translation-back translation method to produce K-WOQ-19 and K-WOQ-9, which were self-administered by 124 patients with PD. We conducted in-depth 10-minute interviews for confirming the presence of the WO phenomenon, and then stratified the participants into groups with and without WO. Diagnostic accuracy was assessed byanalyzing receiver operating characteristic curves. Concurrent validity was assessed using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) andthe Hoehn and Yahr stage with Spearman's rank correlation analysis. Reliability was assessedbased on test-retest Cohen's kappa (κ) values and intraclass correlation coefficients (ICCs).</p><p><strong>Results: </strong>The optimal cutoff scores on the K-WOQ-19 and K-WOQ-9 for WO screening were 4 and 2, respectively. The test-retest ICCs of K-WOQ-19 and K-WOQ-9 were 0.943 and 0.938, respectively. Nineteen of the combined 20 items in K-WOQ-19 and K-WOQ-9 showed moderate-to-substantial agreement (κ=0.412-0.771, <i>p</i><0.001). The scores on the translated scales were significantly correlated with MDS-UPDRS IV scores.</p><p><strong>Conclusions: </strong>K-WOQ-19 and K-WOQ-9 are reliable and valid tools for detecting WO, with optimal cutoff scores of 4 and 2, respectively.</p>","PeriodicalId":15432,"journal":{"name":"Journal of Clinical Neurology","volume":"20 5","pages":"487-492"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}